Key result
Bioinformatics analysis identifies RTN4, COL4A1, and IER3 as potential diagnostic and predictive biomarkers for HCM.
Why the study?
HCM is a heterogeneous monogenic cardiac disease causing arrhythmia, heart failure, and AF, prompting the need to identify biomarkers for treatment, diagnosis, and prediction.
RTN4, COL4A1, and IER3 were identified as potential novel diagnostic biomarkers for hypertrophic cardiomyopathy using integrated bioinformatics analysis.
Answers are grounded in this paper and cite their sources.
These biomarkers should not yet change hypertrophic cardiomyopathy practice; leaves open their diagnostic role pending clinical validation.
HCM is a heterogeneous monogenic cardiac disease that can lead to arrhythmia, heart failure, and atrial fibrillation. This study aims to identify biomarkers that have a positive impact on the treatment, diagnosis, and prediction of HCM through bioinformatics analysis. We selected the GSE36961 and GSE180313 datasets from the Gene Expression Omnibus (GEO) database for differential analysis. GSE36961 generated 6 modules through weighted gene co‐expression network analysis (WGCNA), with the green and grey modules showing the highest positive correlation with HCM (green module: cor = 0.88, p = 2 e − 48; grey module: cor = 0.78, p = 4 e − 31). GSE180313 generated 17 modules through WGCNA, with the turquoise module exhibiting the highest positive correlation with HCM (turquoise module: cor = 0.92, p = 6 e − 09). We conducted GO and KEGG pathway analysis on the intersection genes of the selected modules from GSE36961 and GSE180313 and intersected their GO enriched pathways with the GO enriched pathways of endothelial cell subtypes calculated after clustering single‐cell data GSE181764, resulting in 383 genes on the enriched pathways. Subsequently, we used LASSO prediction on these 383 genes and identified RTN4, COL4A1, and IER3 as key genes involved in the occurrence and development of HCM. The expression levels of these genes were validated in the GSE68316 and GSE32453 datasets. In conclusion, RTN4, COL4A1, and IER3 are potential biomarkers of HCM, and protein degradation, mechanical stress, and hypoxia may be associated with the occurrence and development of HCM.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied Hypertrophic Cardiomyopathy (HCM). Bioinformatics analysis was evaluated on Identification of key genes/biomarkers for HCM. Integrated bioinformatics analysis of GEO datasets identified RTN4, COL4A1, and IER3 as potential key biomarkers for the diagnosis and prediction of hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: